These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16777982)

  • 1. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
    Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
    Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
    Gan L; Yang XL; Liu Q; Xu HB
    J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y; Kahlos K; Näpänkangas U; Kaarteenaho-Wiik R; Säily M; Koistinen P; Pääakkö P; Holmgren A; Kinnula VL
    Clin Cancer Res; 2001 Jun; 7(6):1750-7. PubMed ID: 11410516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bcl-2 inhibits p53-induced apoptosis after genotoxic damage by inhibitors of nuclear import of p53].
    Beham A; Schumacher G; McDonnell TJ; Marin MC; Jauch KW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):113-7. PubMed ID: 14518224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
    Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
    Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
    Seemann S; Hainaut P
    Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin reductase may be essential for the normal growth of hyperbaric oxygen-treated human lens epithelial cells.
    Padgaonkar VA; Leverenz VR; Dang L; Chen SC; Pelliccia S; Giblin FJ
    Exp Eye Res; 2004 Dec; 79(6):847-57. PubMed ID: 15642322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
    Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
    Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN; Stadtman TC
    Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes.
    Koncarevic S; Urig S; Steiner K; Rahlfs S; Herold-Mende C; Sueltmann H; Becker K
    Free Radic Biol Med; 2009 Apr; 46(8):1096-108. PubMed ID: 19439228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation.
    Sakurai A; Yuasa K; Shoji Y; Himeno S; Tsujimoto M; Kunimoto M; Imura N; Hara S
    J Cell Physiol; 2004 Jan; 198(1):22-30. PubMed ID: 14584040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
    Koivusalo R; Mialon A; Pitkänen H; Westermarck J; Hietanen S
    Cancer Res; 2006 Dec; 66(24):11817-24. PubMed ID: 17178878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.